http://www.unboundmedicine.com/medline/ebm/research/capecitabineUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19890692/full_citation/Docetaxel:_its_role_in_current_and_future_treatments_for_advanced_gastric_cancer_Nishiyama M, Wada S 
Docetaxel: its role in current and future treatments for advanced gastric cancer. [Journal Article]
Gastric Cancer 2009; 12(3):132-41.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19889616/full_citation/Capecitabine_after_gastrectomy_for_advanced_gastric_cancer:_have_we_got_the_patient_rightFornaro L, Vasile E, Masi G, et al. 
Capecitabine after gastrectomy for advanced gastric cancer: have we got the patient right? [JOURNAL ARTICLE]
Ann Oncol 2009 Nov 4.
Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19889170/full_citation/Time_to_First_Tumor_Progression_as_Outcome_Predictor_of_a_Second_Trasuzumab_Based_Therapy_beyond_Progression_in_HER_2_Positive_Metastatic_Breast_Cancer_Metro G, Giannarelli D, Gemma D, et al. 
Time to First Tumor Progression as Outcome Predictor of a Second Trasuzumab-Based Therapy beyond Progression in HER-2 Positive Metastatic Breast Cancer. [JOURNAL ARTICLE]
Breast J 2009 Nov 2.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19887868/full_citation/Economic_impact_of_alternative_adjuvant_chemotherapy_regimens_for_stage_III_colon_cancer_Goerner M, Riemer-Hommel P 
Economic impact of alternative adjuvant chemotherapy regimens for stage III colon cancer. [Journal Article]
Onkologie 2009 Nov; 32(11):647-52.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19887866/full_citation/Capecitabine_in_the_routine_treatment_of_advanced_breast_cancer:_results_from_a_non_interventional_observational_study_in_870_patients_Siedentopf F, Gohler T, Hesse T, et al. 
Capecitabine in the routine treatment of advanced breast cancer: results from a non-interventional observational study in 870 patients. [Journal Article, Research Support, Non-U.S. Gov't]
Onkologie 2009 Nov; 32(11):631-6.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19887522/full_citation/Capecitabine_Monotherapy_is_Efficient_and_Safe_in_All_Line_Settings_in_Patients_with_Metastatic_and_Advanced_Breast_Cancer_Amari M, Ishida T, Takeda M, et al. 
Capecitabine Monotherapy is Efficient and Safe in All Line Settings in Patients with Metastatic and Advanced Breast Cancer. [JOURNAL ARTICLE]
Jpn J Clin Oncol 2009 Nov 3.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19887481/full_citation/Phase_I/II_Trial_of_Bevacizumab_and_Radiotherapy_for_Locally_Advanced_Inoperable_Colorectal_Cancer:_Vasculature_Independent_Radiosensitizing_Effect_of_Bevacizumab_Koukourakis MI, Giatromanolaki A, Sheldon H, et al. 
Phase I/II Trial of Bevacizumab and Radiotherapy for Locally Advanced Inoperable Colorectal Cancer: Vasculature-Independent Radiosensitizing Effect of Bevacizumab. [JOURNAL ARTICLE]
Clin Cancer Res 2009 Nov 3.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19880439/full_citation/Preliminary_results_of_phase_II_study_of_capecitabine_and_gemcitabine__CAP_GEM__in_patients_with_metastatic_pretreated_thymic_epithelial_tumors__TETs__Palmieri G, Merola G, Federico P, et al. 
Preliminary results of phase II study of capecitabine and gemcitabine (CAP-GEM) in patients with metastatic pretreated thymic epithelial tumors (TETs). [JOURNAL ARTICLE]
Ann Oncol 2009 Oct 30.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19879716/full_citation/Neoadjuvant_chemoradiotherapy_with_capecitabine_followed_by_laparoscopic_resection_in_locally_advanced_tumors_of_middle_and_low_rectum___Toxicity_and_complications_of_the_treatment_Soumarova R, Skrovina M, Bartos J, et al. 
Neoadjuvant chemoradiotherapy with capecitabine followed by laparoscopic resection in locally advanced tumors of middle and low rectum - Toxicity and complications of the treatment. [JOURNAL ARTICLE]
Eur J Surg Oncol 2009 Oct 29.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19877119/full_citation/Thymidine_phosphorylase_to_dihydropyrimidine_dehydrogenase_ratio_as_a_predictive_factor_of_response_to_preoperative_chemoradiation_with_capecitabine_in_patients_with_advanced_rectal_cancer_Boskos CS, Liacos C, Korkolis D, et al. 
Thymidine phosphorylase to dihydropyrimidine dehydrogenase ratio as a predictive factor of response to preoperative chemoradiation with capecitabine in patients with advanced rectal cancer. [JOURNAL ARTICLE]
J Surg Oncol 2009 Oct 29.
Abstract | Full Citation